http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2696573-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a04c6c280082bdf70eacef1d93f2dc6f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2019-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10a04a0639af6141613df9eef039aa38
publicationDate 2019-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2696573-C1
titleOfInvention Antimicrobial medicinal preparation in the form of tablets of furacilin with accelerated release
abstract FIELD: pharmaceutics.SUBSTANCE: invention refers to chemical-pharmaceutical industry, namely to a composition of a solid dosage form of a sustained-release furacilin preparation for preparing an external and topical solution. Antimicrobial medicinal preparation in the form of tablets with accelerated release contains (wt%): active substance – furacilin (nitrofural) – 2.0–2.5 %; filler – sodium chloride – 87.5–94 %; superdisintegrant with particle size of 110–140 mcm and peroxide content not exceeding 440 ppm – 2–5 %; binder with average molecular weight of 25,000–30,000 – 2–5 %. Superdisintegrant can be crospovidone, and the binding substance can be kollidone.EFFECT: disclosed is a sustained-release furacilin preparation.4 cl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2772430-C1
priorityDate 2019-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2554768-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2533261-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409298605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5353356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917

Total number of triples: 25.